IE
PROF

Israel Englander’s Profound Medical PROF Stock Holding History

Israel Englander’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,824
Closed -$211K – 6244
2025
Q4 		$211K Buy
+26,824
New +$172K ﹤0.01% 5448
2025
Q2 		– Sell
-12,758
Closed -$74.2K – 6236
2025
Q1 		$74.2K Buy
+12,758
New +$88.1K ﹤0.01% 5486
2024
Q4 		– Sell
-53,633
Closed -$427K – 6357
2024
Q3 		$427K Buy
+53,633
New +$485K ﹤0.01% 4951
2021
Q4 		– Sell
-29,107
Closed -$426K – 7260
2021
Q3 		$426K Buy
+29,107
New +$443K ﹤0.01% 5494
2021
Q2 		– Sell
-21,606
Closed -$435K – 6986
2021
Q1 		$435K Sell
21,606
-1,953
-8% -$46.8K ﹤0.01% 4935
2020
Q4 		$484K Sell
23,559
-16,511
-41% -$304K ﹤0.01% 4224
2020
Q3 		$707 Buy
40,070
+26,494
+195% +$421K ﹤0.01% 3373
2020
Q2 		$230K Sell
13,576
-15,624
-54% -$197K ﹤0.01% 3783
2020
Q1 		$284K Buy
+29,200
New +$379K ﹤0.01% 3205

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Israel Englander's PROF Position: Q1 2026 in Review

Israel Englander sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 26,824 shares — an estimated $211K sold.

Israel Englander first reported a position in PROF in Q1 2020 and held it in 9 quarters. The position peaked at $484K in Q4 2020. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Israel Englander reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 26,824 Profound Medical shares in Q1 2026, an estimated $211K.
  • Israel Englander first reported a position in Profound Medical in Q1 2020 and held it in 9 quarters.
  • Israel Englander's Profound Medical position peaked at $484K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.